Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.75% 0.27% 155.42M 41332.13
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
0.80% 95.00% 48.28M

Basic Info

Investment Strategy
The Fund seeks to provide long-term growth. Under normal circumstances, the Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology.
General
Security Type Exchange-Traded Fund
Equity Style Multi Cap Growth
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name Tema
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
--
--
--
--
-5.35%
42.92%
6.36%
27.67%
15.90%
21.82%
-18.14%
23.79%
18.67%
21.09%
2.32%
--
54.29%
-3.99%
-42.27%
-7.61%
-0.73%
17.27%
14.55%
--
--
-3.96%
-19.69%
5.70%
1.55%
21.79%
1.76%
--
--
--
--
--
-4.30%
23.90%
1.81%
23.22%
12.75%
19.59%
-4.93%
3.64%
0.55%
15.00%
3.46%
As of February 20, 2026.

Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.35%
Stock 99.34%
Bond 0.28%
Convertible 0.00%
Preferred 0.00%
Other 0.02%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks to provide long-term growth. Under normal circumstances, the Tema Oncology ETF seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology.
General
Security Type Exchange-Traded Fund
Equity Style Multi Cap Growth
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name Tema
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders